Qualigen Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS. 

CEO
Michael S. Poirier
CEOMichael S. Poirier
Employees
46
Employees46
Headquarters
Carlsbad, California
HeadquartersCarlsbad, California
Founded
2004
Founded2004
Employees
46
Employees46

QLGN Key Statistics

Market cap
11.26M
Market cap11.26M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
230.39K
Average volume230.39K
High today
$0.32
High today$0.32
Low today
$0.26
Low today$0.26
Open price
$0.2802
Open price$0.2802
Volume
484.80K
Volume484.80K
52 Week high
$3.12
52 Week high$3.12
52 Week low
$0.26
52 Week low$0.26

QLGN Earnings

-$3.17
-$2.11
-$1.06
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.